Anagnostou, Theodora
Sakemura, Reona
Forsman, Cynthia L.
Patnaik, Mrinal S. http://orcid.org/0000-0001-6998-662X
Paludo, Jonas http://orcid.org/0000-0002-7350-5531
Gastineau, Dennis A.
Buadi, Francis K.
Porrata, Luis F.
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Gertz, Morie A.
Lacy, Matha Q.
Dispenzieri, Angela
Gonsalves, Wilson I.
Lehman, Julia S.
Hogan, William J. http://orcid.org/0000-0002-5841-4105
Hashmi, Shahrukh K. http://orcid.org/0000-0002-8914-7927
Alkhateeb, Hassan
Shah, Mithun V.
Litzow, Mark R.
Kenderian, Saad S.
Funding for this research was provided by:
American Society of Hematology (RTAF)
Mayo Clinic (N/A)
Article History
Received: 10 February 2020
Revised: 21 February 2020
Accepted: 25 February 2020
First Online: 11 March 2020
Compliance with ethical standards
:
: SSK is an inventor on patents in the field of CAR-T cell immunotherapy that are licensed to Novartis, Humanigen and Mettaforge. SSK receives research funding from Kite, Gilead, Juno, Celegene, Novartis, Humanigen, Tolero, Sunesis, Lentigen, and Morphosys. SSK serves on advisory boards for Kite, and Humanigen. These disclosures are not directly related to this work. The rest of the authors report no financial disclosures.